Navigation Links
Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
Date:3/19/2012

tegrated drug delivery and drug development company in healthcare, with registered offices in Switzerland and the United States. It is focused on the research and development of innovative and patented drug delivery systems as well as innovative pharmaceutical products primarily for oral and topical administration.

For more information about APR, please visit www.apr.ch  


'/>"/>
SOURCE Nautilus Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Intellect Neurosciences, Inc. to Present at 10TH Annual BIO Investor Forum
2. Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
3. Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
4. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
5. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
6. Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting
7. Proteonomix Announces a Private Placement of $3.8 Million
8. Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
9. ARUP Laboratories Announces Creation of Business Innovations Division
10. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
11. Regeneron Announces March 2012 Investor Conference Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through the ... “The Doctor’s Plague.” In this time period, doctors did not ... at times, to the death of vulnerable patients. In the ... that they may be unwittingly transmitting herpes viruses to their ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... store, mine and ... success, NEWTON, Mass., June 23 Today, TCN ... a new,product, "Center of Excellence," designed to establish secure, ... The goal is to standardize work flow and make ...
... 23 MedPredict has published a,new report ... pharma and,biotech companies hoping to identify the ... entitled "Thought Leader Insight & Analysis:,Pain/Analgesics," is ... panel of,specialists in anesthesiology, psychiatry, rheumatology, gastroenterology,and ...
... Pa., June 23 The Premier healthcare,alliance ... Diagnostics (http://www.siemens.com/diagnostics ) was one of ... of more than 800 eligible suppliers,representing the ... The,award recognizes suppliers whose performance exceeds the ...
Cached Biology Technology:TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment 2TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment 3TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment 4In Pain Market, Huge Unmet Needs, Tough Regulatory Environment Challenge Pharmaceutical Companies, According to MedPredict 2Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance 2Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance 3
(Date:4/17/2014)... Medical Branch at Galveston are the first to ... cervical cancer should begin colorectal cancer screening earlier ... finding a high incidence of secondary colorectal cancers ... new recommendations that the younger women in this ... after their initial cervical cancer diagnosis instead of ...
(Date:4/17/2014)... uncovered a new way the immune system may fight ... to use immune cells to treat illness. , The ... immunological equivalent of "neighborhood police" specialized squads of ... instead of an entire city, the body. , Scientists ... have shown that the liver, skin and uterus each ...
(Date:4/17/2014)... special feature of The Proceedings of ... published April 29, raises a number of startling questions ... of us take for granted. At the end of ... the globe shifted from hunting animals and gathering fruits ... seems so straightforward and yet the more scientists learn, ...
Breaking Biology News(10 mins):Radiation therapy for cervical cancer increases risk for colorectal cancer 2Some immune cells defend only 1 organ 2Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
... but nearly half the world,s population still cooks and ... wood, animal dung, charcoal and other polluting solid fuels. ... & Technology describes impressive progress being made to ... Susan C. Anenberg and colleagues describe the health ...
... do rose petals have rounded ends while their leaves are ... the open access journal PLOS Biology , scientists from ... reveal that the shape of petals is controlled by a ... Leaves and petals perform different functions related to their shape. ...
... of private and public entities conducting research in synthetic ... to the latest version of an interactive map produced ... International Center for Scholars. The map is available online ... of research focused on the design and construction of ...
Cached Biology News:How petals get their shape 2Synthetic biology research community grows significantly 2
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
...
... the 9, 10, 12, and 13 positions. It ... for the quantification of 13(S)-HODE by GC- or ... linoleic acid with plant and mammalian lipoxygenases. It ... tumor cells to the endothelium at concentrations around ...
...
Biology Products: